1825 Connecticut Avenue NW,,Suite 400
Washington , DC, 20009
Washington , DC, 20009
Summary
The fund seeks capital appreciation in the long term by investing in large-size companies in the United States.
The investment process is designed to highlight quality companies that exhibit consistent growth in earnings and are trading at a discount to their estimated intrinsic value.
The research team is looking for companies with strong balance sheets, sustainable cash flow, enduring competitive advantages More
Link
Directors
Dec 7, 2023- Theodore H. Eliopoulos
- Cari M. Dominguez
- Miles D. Harper, III
- Karen Fang
- Eddie Ramos
- Anthony A. Williams
- Richard L. Baird, Jr.
- John G. Guffey, Jr.
- Alice Gresham Bullock
- Joy V. Jones
Chief Compliance Officer
- Hope L. Brown
Fund Manager(s)
- Joseph Hudepohl
- Jeffrey Miller
- Robert Walton
- Lance Garrison
Price
- 52-Week High/Low
- $86.79 - $68.48
- Turnover
- 13%
- Expense Ratio
- 0.91%
Company Name |
Holding |
| Thermo Fisher Scientific Inc | 4.51 % |
| Intuit Inc | 3.7 % |
| Amphenol Corp | 3.27 % |
| Dollar General Corp | 1.93 % |
| Agilent Technologies Inc | 1.48 % |
| Air Products and Chemicals Inc | 1.14 % |
| Costco Wholesale Corp | 1.03 % |
| MSCI Inc | 0.98 % |
| Accenture PLC | 0.96 % |
| NIKE Inc | 0.85 % |
| More | 0.85 % |
Documents
Performance
YTD
-
3 Year
16.78%
5 Year
41.93%
Best
33.41%
2009
Worst
-35.37%
2008
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | 5.6% | 4% | -10.5% | 2.3% | -13.4% | 17.1% | 2.7% | 6.9% | 0.4% |
| Q2 | - | -3.1% | 5.1% | -12.5% | 9.6% | 19.8% | 6.3% | 5% | 5.4% | -0.3% |
| Q3 | - | - | -4.3% | -4.1% | -0.6% | 7.1% | 2.5% | 8.2% | 4.4% | 3.3% |
| Q4 | - | - | 11% | 6.3% | 11.5% | 8.8% | 2.3% | -8.8% | 6.5% | -0.9% |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | 0.2% | 4.4% | 0.9% | -4.8% | - | - | - | - | - | - | - | - |
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 2% | 16% | -20% | 24% | 21% | 33% | 5% | 26% | 3% |
Alpha
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| CSIEX | - | 2% | 16% | -20% | 24% | 21% | 33% | 5% | 26% | 3% |
| Russell 1000 | - | -8% | 36% | -27% | 27% | 37% | 35% | -3% | 28% | 5% |
| Alpha | - | 9% | -20% | 7% | -2% | -16% | -2% | 8% | -3% | -3% |